Evaluation of an individualized starting-dose of niraparib in the PRIMA/ENGOT-OV26/GOG-3012 study.

出版年份 2020 全文链接

标题

作者

关键词

出版物

Volume 38, Issue 15_suppl, Pages 6050-6050

出版商

American Society of Clinical Oncology (ASCO)

发表日期

2020-05-25

DOI

10.1200/jco.2020.38.15_suppl.6050

Discuss science. Find collaborators. Network.

Join a conversation

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started